Demand for laser, radiofrequency, and ultrasound platforms is accelerating as private-equity-backed medspa chains consolidate and a broader patient base emerges. Beyond traditional aesthetics, providers are increasingly addressing the physical side effects of weight-loss drugs, creating a specialized demand category for body-contouring and skin-tightening technology. Market Decipher reports that this 'GLP-1 face' and body-laxity trend could generate a $2 billion procedure market by 2030.
While the United States remains the industry anchor with a projected 2036 value of $8.95 billion, the fastest growth is occurring in emerging and high-density markets. China leads the forecast with a 15.1% CAGR, fueled by rapid clinic expansion in tier-2 and tier-3 cities. Similarly, South Korea, Saudi Arabia, and Brazil are outpacing established Western European markets, benefiting from high medical tourism rates and significant investments in private aesthetic infrastructure. Manufacturers are responding by focusing on multi-modality platforms that offer versatility, as clinics prioritize clinical evidence and physician-backed equipment over lower-cost alternatives.





Comments (0)
No comments yet. Be the first!